⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

LAURUSLABS - Swing Trade Analysis with AI Signals

← Back to List

⭐ Rating: 4.3

Last Updated Time : 19 Sept 26, 05:49 am

Key Parameters

⭐ Swing Trade Rating: 4.3

RSI62.2
MACD43.4
DMA 501,787 ₹
DMA 2001,390 ₹
Volume27,09,942
Avg Vol 1Wk23,22,299
High / Low1,982 ₹
52w Index97.6 %
Show all parameters (20 more)
Stock CodeLAURUSLABS
Market Cap1,05,129 Cr.
Current Price1,954 ₹
Stock P/E120
Book Value97.3 ₹
Dividend Yield0.10 %
ROCE16.0 %
ROE15.2 %
Face Value2.00 ₹
Chg in FII Hold2.18 %
Chg in DII Hold-0.23 %
PAT Qtr290 Cr.
PAT Prev Qtr192 Cr.
Low price823 ₹
High price1,982 ₹
PEG Ratio-163
Debt to equity0.40
Qtr Profit Var83.6 %
EPS16.2 ₹
Industry PE34.8

🧾 Trade Setup

Enter a long position at 1925 ₹. Target initial exit at 1980 ₹ – this represents a comfortable 3% profit target aligned with the recent price action and analyst ratings. A trailing stop loss of 1870 ₹ should be implemented to manage downside risk if momentum stalls. This stock presents an attractive swing trading opportunity given the current bullish sentiment and demonstrable growth.

✅ Positive

The stock is experiencing significant near-term momentum, evidenced by a 52-week high and a substantial quarter-over-quarter profit surge (83.6%). Furthermore, positive analyst ratings ("Buy") are bolstering investor confidence.

⚠️ Limitation

Despite the strong recent performance, the extremely elevated P/E ratio (120) compared to the industry average (34.8) presents a notable risk of overvaluation and potential correction. The high debt-to-equity ratio of 0.4 also warrants caution.

📈 Company Positive News

Recent news indicates an "Buy" rating from Univest, suggesting continued positive sentiment surrounding Laurus Labs.

🏭 Industry

The pharmaceutical sector is currently experiencing robust growth driven by increasing demand for generic drugs and active pharmaceutical ingredients (APIs). However, heightened regulatory scrutiny and competitive pressures remain prevalent within the industry.

Choose Technical Analysis or Fundamental Analysis above to load it.

How LAURUSLABS Rates Across All Strategies

Swing Trade
★ 4.3
You're viewing this analysis below.
★ 3.8
Optimal buy price: 1940 ₹.
★ 3.2
An ideal entry zone would be between 1,850 ₹ and 1,920 ₹, capitalizin…
★ 3.7
An entry zone could be established around 1,850 ₹ based on a conserva…

NIFTY 50 · Swing Trading

NEXT 50 · Swing Trading

MIDCAP · Swing Trading

SMALLCAP · Swing Trading